2348 logo

Dawnrays Pharmaceutical (Holdings) Limited Stock Price

SEHK:2348 Community·HK$1.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2348 Share Price Performance

HK$0
-1.23 (-100.00%)
HK$0
-1.23 (-100.00%)
Price HK$0

2348 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet average dividend payer.

2 Risks
1 Reward

Dawnrays Pharmaceutical (Holdings) Limited Key Details

CN¥1.1b

Revenue

CN¥603.8m

Cost of Revenue

CN¥509.5m

Gross Profit

CN¥333.0m

Other Expenses

CN¥176.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 27, 2026
0.12
45.76%
15.85%
0.3%
View Full Analysis

About 2348

Founded
1995
Employees
1116
CEO
Liwei Yu
WebsiteView website
www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.

Recent 2348 News & Updates

Recent updates

No updates